You searched for "medialisation"
COVID-19 and ENT training: experiences from around the world
Here, ENT trainees share their experiences of adaptations to both clinical practice and training during the COVID-19 pandemic. We welcome other colleagues from around the world to share their experiences with us via social media or the website. Australia Olivia...Random-pattern skin flaps: part 2 - rhomboid and bilobed flaps
In the second of our series on local skin flaps (see Part 1 here, Part 3 here and Part 4 here), the authors describe more techniques and examples of various skin flaps that trainees should find very interesting. Rhomboid flap...
Gamma Knife surgery for persistent or recurrent trigeminal neuralgia
Treatment of trigeminal neuralgia continues to be challenging. The treatment options include pharmacotherapy, or failing this, surgical options like microvascular decompression (MVD), radiofrequency ablation, pencil beam convolution and Gamma Knife surgery. The authors of this article have presented a series...
Assessment of the incidence of LPR in the Greek population using the Reflux Symptom Index
Using the self-administered nine-item Belafsky Reflux Symptom Index (RSI) questionnaire, the authors of this article assessed the prevalence of laryngopharyngeal reflux (LPR) in the general adult Greek population as well as predisposing and associated factors for developing LPR. They found...
An overview of microsurgical reconstruction of the head and neck worldwide
Microsurgical reconstruction is an integral part of the treatment following ablation for malignancy or trauma. Currently there are no clear treatment guidelines following tumour resection. This was recognised a few years ago and in 2008 various collaborative groups were founded...
Location, location, location: How to get the steroid where you need it, in chronic rhinosinusitis
What almost all current guidelines on chronic rhinosinusitis have in common is the importance of intranasal steroid (INCS) use. However, it is increasingly understood that the efficacy of INCS depends on their efficient delivery to the point of need, i.e....
Can we predict how much benefit patients will get from ESS with a novel monoclonal antibody
Mepolizumab (Nucala) is a humanised IgG1 monoclonal antibody that acts as an IL-5 antagonist. It has been shown to be highly effective in treating severe asthma. It is hypothesised that it will be effective for patients with recalcitrant CRSwNP. This...
